# Reproductive Technologies, Inc. – FDA Inspection, Aug 16, 2019

Source: https://www.keypedia.com/records/fda_inspections/reproductive-technologies-inc/57e50f00-bfa5-4927-a5b1-3888f3de498b
Source feed: FDA_Inspections

> FDA inspection 1100185 of Reproductive Technologies, Inc., August 16, 2019. Classification: Official Action Indicated (OAI). 4 citations under 21 CFR part 1271. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1100185
- Company Name: Reproductive Technologies, Inc.
- Inspection Date: 2019-08-16
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4
- Enforcement Type: WARNING_LETTER

## Related Documents

- [FDA Inspection 1254426 - 2024-11-18](https://www.keypedia.com/records/fda_inspections/reproductive-technologies-inc/dc81b15b-899c-4381-9a5f-624d46bbe7c2)
- FDA Inspection 1153089 - 2021-09-13
- FDA Inspection 983894 - 2016-09-08
- FDA Inspection 861157 - 2013-12-20
- FDA Inspection 768779 - 2012-02-17

## Related Officers

- [Company Rep](https://www.keypedia.com/people/yvonne-c-wilkes/44e7b094-d09a-48f0-a0ee-f1a6506f935a)

Company: https://www.keypedia.com/companies/reproductive-technologies-inc/81a46c28-125d-4e9e-ba8b-1d521dff2b44

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
